IL-1 alpha and NTHi's Role in Up-Regulating Beta-Defensin 2
Author Information
Author(s): Moon Sung-Kyun, Lee Haa-Yung, Pan Huiqi, Takeshita Tamotsu, Park Raekil, Cha Kiweon, Andalibi Ali, Lim David J
Primary Institution: The Gonda Department of Cell and Molecular Biology, House Ear Institute, Los Angeles, CA, USA
Hypothesis
Can IL-1 alpha synergistically enhance the up-regulation of beta-defensin 2 in middle ear epithelial cells when exposed to nontypeable Haemophilus influenzae (NTHi)?
Conclusion
IL-1 alpha is secreted by middle ear epithelial cells upon exposure to NTHi components and synergistically acts with these molecules to up-regulate beta-defensin 2 via the p38 MAP kinase pathway.
Supporting Evidence
- Middle ear epithelial cells released IL-1 alpha when stimulated by NTHi components.
- IL-1 alpha acted in a synergistic manner with NTHi to up-regulate beta-defensin 2.
- The synergistic effect was mediated by the p38 MAP kinase pathway.
- Only IL-1 alpha treatment resulted in an up-regulation of beta-defensin 2 mRNA in HMEEC and A549 cells.
Takeaway
When certain bacteria get into the ear, they can make the ear cells release a helper protein called IL-1 alpha, which then helps those cells make a special defense protein to fight off the bacteria.
Methodology
The study used human middle ear epithelial cell lines and a murine model of acute otitis media, employing cytokine macroarray analysis, real-time quantitative PCR, and luciferase assays.
Potential Biases
Potential bias in the selection of cell lines and animal models may affect the generalizability of the findings.
Limitations
The study primarily focused on in vitro and murine models, which may not fully replicate human responses.
Participant Demographics
Eighteen male C57BL/6 mice were used in the animal studies.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website